New Zealand King Salmon's (NZK) 1H23 pro-forma EBITDA result was slightly below our expectations, mostly due to higher than expected costs which included lingering effects from the 2022 summer mortality event
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.